Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/28/23 → 6/27/28 |
Funding
- Merck Sharp and Cohme Corporation: $12,750.00
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V117 Formulation C in Healthy Adults
- Rupp, Richard (PI)
Project: Research project